AxoGen, Inc. (AXGN) vs UFP Technologies, Inc. (UFPT)
- AxoGen, Inc. AXGN 49.64 +1.83%
- UFP Technologies, Inc. UFPT 301.40 +0.53%
AxoGen, Inc. and UFP Technologies, Inc. are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.9B against $2.3B — 1.3× the size. AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; UFP Technologies, Inc. trades at 30.1×. AxoGen, Inc. grew revenue faster over the last twelve months: 24.3% against 8.62%. UFP Technologies, Inc. has the higher net margin (11.8% vs −12.0%) and the higher return on invested capital (11.2% vs −5.27%). Across the 20 metrics below, UFP Technologies, Inc. leads on 15 and AxoGen, Inc. on 5.
Valuation
Profitability
| Metric | AXGN | UFPT | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 28.95% | 57.76% |
| Operating margin | (5.17%) | 15.48% | (15.07%) |
| Net margin | (11.96%) | 11.78% | (14.45%) |
| Free cash flow margin | 7.50% | 0.00% | (3.88%) |
| Return on equity | (10.35%) | 0.00% | (10.35%) |
| Return on assets | (8.33%) | 11.46% | (17.26%) |
| Return on invested capital | (5.27%) | 11.20% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack